I am an academic medical oncologist specializing in genitourinary cancers. I care for patients with prostate, bladder, and testicular cancer.
I am interested in clinical trial development and serve as overall PI and site PI of several DFHCC clinical trials that investigate immuno-oncology and targeted agents for GU cancers. I am a member of a team funded by a Challenge Award from the Prostate Cancer Foundation that is exploring immuno-oncology in prostate cancer. I am also interested in biomarkers for differentiating indolent from potentially aggressive "low-risk" prostate cancer, a project supported by a grant from the Department of Defense. I lead the GU Rapid Autopsy project at DFHCC, which offers patients the opportunity to leave a scientific legacy and offers scientists the opportunity to study tumor hetereogeneity and mechanisms of resistance to treatment.
I am also interested in improving physician communication about difficult topics ranging from clinical trial enrollment to advance-care planning. I have published studies of the integration of palliative care into oncologic care and end-of-life discussions between residents and cancer patients, and I have been an invited speaker at the Boston Prostate Cancer Support Group.